What’s the Difference? STAAR GPS-L™ vs. STAAR GPS-D™

Not all GLP-1 therapies are created equal.

But the biggest mistake clinics and patients make? Thinking GLP-1s alone are enough.

Whether you’re using liraglutide, dulaglutide, semaglutide, or compounded variants — results remain limited without two critical additions: pramlintide and SLM+.

⚠️  Liraglutide and Dulaglutide Alone = Suboptimal

Both liraglutide (Victoza®/Saxenda®) and dulaglutide (Trulicity®) activate the GLP-1 receptor — reducing appetite and improving glycemic control. But in isolation, they:

• Fail to address metabolic adaptation (your body’s tendency to stall weight loss)

• Do not support muscle preservation

• Leave amylin and GIP pathways unaddressed

• Often result in plateaus or incomplete weight loss
  

These GLP-1s are useful but insufficient on their own. They are the foundation — not the blueprint.

🧭 Enter STAAR GPS™: Building a Complete Protocol

The STAAR GPS Protocol™ enhances the effects of any GLP-1 by strategically adding:

• Pramlintide – a synthetic amylin analog that increases satiety, slows gastric emptying, and synergizes with GLP-1s

• SLM+ – a science-backed supplement containing berberine HCl and banaba leaf to support insulin sensitivity, mimic GIP-like metabolic activity, and help preserve lean mass

🧪 L vs. D: Which GPS Protocol Is Right for You?

💡 Important:

While dulaglutide is a weekly injection, GPS-D™ patients still require daily injections.

• Day 1: Combined dulaglutide + pramlintide injection

• Days 2–7: Standalone pramlintide injections

This ensures consistent amylin support throughout the week, as pramlintide has a short half-life and must be administered daily for optimal appetite and glycemic regulation.

🔄 Can GPS Be Used with Other GLP-1s? YES.

You don’t need to start over.

If you’re already taking:

• Semaglutide (Ozempic®, Wegovy®)

• Tirzepatide (Mounjaro®, Zepbound®)

• Compounded GLP-1 formulas

…you can still enhance your results by adding pramlintide + SLM+ through the GPS model.

STAAR GPS is a universal protocol.

It enhances any GLP-1 therapy — branded, compounded, or manufactured.

💬 Provider Tip

“Patients already on semaglutide see a second wave of weight loss when we layer in GPS components. It’s a metabolic unlock.”

— Dr. Sean V., Weight Management Specialist

⚙️ Where to Start

1. Choose your GLP-1 base: Liraglutide or Dulaglutide

2. Add STAAR GPS components: Pramlintide + SLM+

3. Follow your protocol consistently with your provider’s guidance

🧠 Key Takeaways

• GLP-1 monotherapy is outdated

• Pramlintide + SLM+ = required for optimal results

• GPS-L™ and GPS-D™ are customizable to patient needs

• You can enhance any GLP-1 — even if already prescribed

⚠️ Disclaimers

Medical Disclaimer: This content is provided for educational purposes only and is not intended as medical advice. The STAAR GPS Protocol™ must be prescribed and managed by a licensed healthcare provider. Individual results may vary.

Supplement Disclaimer: SLM+ by STAAR LABS is a dietary supplement. These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease.

Compliance Note: STAAR LABS does not sell or distribute prescription medications. All pharmaceutical components of the GPS Protocol™ are provided through licensed healthcare providers and regulated compounding pharmacies.

Research Disclosure: STAAR LABS collaborates with clinics and licensed professionals to develop innovative metabolic health strategies that integrate pharmaceutical and nutraceutical interventions.